Cowen And Company, LLC Vertex Pharmaceuticals Inc Put Options Transaction History

Cowen And Company, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 05, 2022	SELL	$234.96 - $292.55 $3.52 Million - $4.39 Million	-15,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $2.66 Million - $3.35 Million	15,000 New	15,000 $143,000
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $974,948 - $1.15 Million	-5,200 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$207.02 - $241.31 $476,146 - $555,013	-2,300 Reduced 30.67%	5,200 $189,000
Q4 2020 Feb 08, 2021	BUY	$207.01 - $276.09 $1.55 Million - $2.07 Million	7,500 New	7,500 $118,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.